Utah Medical Products (NASDAQ:UTMD) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $66.86 and traded as high as $71.53. Utah Medical Products shares last traded at $69.33, with a volume of 10,441 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Utah Medical Products has an average rating of “Hold”.

Utah Medical Products Stock Performance

The company has a market capitalization of $220.47 million, a price-to-earnings ratio of 20.51 and a beta of 0.36. The company has a 50-day moving average price of $66.86 and a 200-day moving average price of $64.32.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%. The business had revenue of $8.72 million for the quarter.

Utah Medical Products Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 3rd. Investors of record on Wednesday, June 17th were given a $0.31 dividend. The ex-dividend date was Wednesday, June 17th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. Utah Medical Products’s dividend payout ratio is currently 36.69%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Brandes Investment Partners LP raised its position in shares of Utah Medical Products by 4.0% during the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock worth $19,660,000 after purchasing an additional 13,392 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Utah Medical Products by 1.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 200,032 shares of the medical instruments supplier’s stock valued at $12,596,000 after purchasing an additional 2,566 shares during the period. Geode Capital Management LLC grew its position in shares of Utah Medical Products by 6.5% in the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock valued at $6,537,000 after purchasing an additional 7,040 shares during the period. Minerva Advisors LLC increased its stake in Utah Medical Products by 0.6% during the 4th quarter. Minerva Advisors LLC now owns 93,615 shares of the medical instruments supplier’s stock worth $5,239,000 after purchasing an additional 557 shares in the last quarter. Finally, Rice Hall James & Associates LLC raised its holdings in Utah Medical Products by 5.4% during the 1st quarter. Rice Hall James & Associates LLC now owns 67,882 shares of the medical instruments supplier’s stock worth $4,208,000 after buying an additional 3,484 shares during the period. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).